The therapeutic role of taurine in ischaemia-reperfusion injury

Current Pharmaceutical Design

Volumn 10, Issue 19, 2004, Pages 2401-2410

  Kingston, R ^a,b   Kelly, C J ^a   Murray, P ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b NONE   (Ireland)

Author keywords

Antioxidants; Ischaemia reperfusion injury; Lipid peroxidation; Oxidative stress; Reperfusion; Taurine

Indexed keywords

21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 AMINOSTEROID; ACETYLCYSTEINE; ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASCORBIC ACID 2 [3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2 (4,8,12 TRIMETHYLTRIDECYL) 2H 1 BENZOPYRAN 6 YL HYDROGEN PHOSPHATE] POTASSIUM; DEFEROXAMINE; EURO COLLINS SOLUTION; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON CHELATING AGENT; LAZAROID; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; OXYGEN RADICAL; PENTOXIFYLLINE; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; RETINOL; SUPEROXIDE; SUPEROXIDE DISMUTASE; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNINDEXED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; CORONARY ARTERY BYPASS GRAFT; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART VALVE SURGERY; HUMAN; INDUCED HYPOTHERMIA; INTESTINE ISCHEMIA; IRON CHELATION; ISCHEMIA; KIDNEY ISCHEMIA; LIPID PEROXIDATION; LIVER ISCHEMIA; MUSCLE ISCHEMIA; MUSCLE PERFUSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; RETINA ISCHEMIA; REVIEW; SCAVENGING SYSTEM; SKELETAL MUSCLE;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; REPERFUSION INJURY; TAURINE; VITAMIN E;

EID: 3042826533     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043384015     Document Type: Review

References (114)

1. Redmond HP, Stapleton PP, Neary P, Bouchier-Hayes DJ. Immunonutrition: the role of taurine. Nutrition 1998; 14(7-8): 599-604.
2. Stapleton PP, O'Flaherty L, Redmond HP, Bouchier-Hayes DJ. Host defense--a role for the amino acid taurine? JPEN J Parenter Enteral Nutr 1998; 22(1): 42-48.
3. Ament ME, Geggel HS, Heckenlively JR, Martin DA, Kopple J. Taurine supplementation in infants receiving long-term total parenteral nutrition. J Am Coll Nutr 1986; 5(2): 127-135.
4. Schaffer S, Azuma J, Takahashi K, Mozaffari M. Why is taurine cytoprotective? Adv Exp Med Biol 2003; 526: 307-321.
5. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 1977; 9(8): 605-616.
6. Valer G, Khoschsorur GA, Almdahl SM, Esterbauer H, Vaage J. Lipid peroxidation in open-heart surgery. Perfusion 1994; 9(4): 277-283.
7. Soong CV, Young IS, Hood JM, Rowlands BJ, Trimble ER, Barros D'S. The generation of byproducts of lipid peroxidation following carotid endarterectomy. Eur J Vasc Endovasc Surg 1996; 12(4): 455-458.
8. Khaira HS, Maxwell SR, Thomason H, Thorpe GH, Green MA, Shearman CP. Antioxidant depletion during aortic aneurysm repair. Br J Surg 1996; 83(3): 401-403.
9. Holoma, Zahorec R, Kusy J, Pecha. Biochemical monitoring in patients during revascularization surgery. Vasa 1995; 24(1): 23-28.
10. Friedl HP, Till GO, Trentz O, Ward PA. Role of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients. Klin Wochenschr 1991; 69(21-23): 1109-1112.
11. Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153(2): 557-566.
12. Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a review. Microsurgery 1993; 14(3): 165-175.
13. al-Qattan MM. Ischaemia-reperfusion injury. Implications for the hand surgeon. J Hand Surg [Br] 1998; 23(5): 570-573.
14. Sakorafas GH, Tsiotos GG, Sarr MG. Ischemia/Reperfusion-Induced pancreatitis. Dig Surg 2000; 17(1): 3-14.
15. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993; 49(3): 481-493.
16. Kelly C, Creagh T, Grace PA, Bouchier-Hayes D. Regional hypothermia protects against tourniquet neuropathy. Eur J Vasc Surg 1992; 6(3): 288-292.
17. Wright JG, Araki CT, Belkin M, Hobson RW. Postischemic hypothermia diminishes skeletal muscle reperfusion edema. J Surg Res 1989; 47(5): 389-396.
18. Skjeldal S, Torvik A, Nordsletten L, Kirkeby OJ, Grogaard B, Svindland A, et al. Local hypothermia during ischemia or reperfusion in skeletal muscles. Res Exp Med (Berl) 1993; 193(2): 73-80.
19. Fish JS, McKee NH, Kuzon WM, Plyley MJ. The effect of hypothermia on changes in isometric contractile function in skeletal muscle after tourniquet ischemia. J Hand Surg [Am] 1993; 18(2): 210-217.
20. Erdogan D, Omeroglu S, Sarban S, Atik OS. Prevention of oxidative stress due to tourniquet application. Analysis of the effects of local hypothermia and systemic allopurinol administration. Acta Orthop Belg 1999; 65(2): 164-169.
21. Awerbuck D, Luong V, Plyley MJ, McKee NH. Skeletal muscle form and function after 4 hr ischemia-hypothermia. J Surg Res 1994; 57(4): 480-486.
22. Sakamaki F, Hoffmann H, Munzing S, Krombach F, Messmer K, Schildberg FW. Effects of lung preservation solutions on PMN activation in vitro. Transpl Int 1999; 12(2): 113-121.
23. Aeba R, Killinger WA, Keenan RJ, Yousem SA, Hamamoto I, Hardesty RL, et al. Lazaroid U74500A as an additive to University of Wisconsin solution for pulmonary grafts in the rat transplant model. J Thorac Cardiovasc Surg 1992; 104(5): 1333-1339.
24. Chiang CH, Wu K, Yu CP, Perng WC, Yan HC, Wu CP, et al. Protective agents used as additives in University of Wisconsin solution to promote protection against ischaemia-reperfusion injury in rat lung. Clin Sci (Colch) 1998; 95(3): 369-376.
25. Minor T, Yamaguchi T, Isselhard W. Effects of taurine on liver preservation in UW solution with consecutive ischemic rewarming in the isolated perfused rat liver. Transpl Int 1995; 8(3): 174-179.
26. Minor T, Yamaguchi T, Klauke H, Wingenfeld P, Michalk D, Isselhard W. Taurine reduces experimental liver injury after cold ischemic preservation and a period of rewarming prior to reperfusion. Adv Exp Med Biol 1996; 403: 157-161.
27. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
28. Hawaleshka A, Jacobsolin E. Ischaemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth 1998; 45(7): 670-682.
29. Carroll CM, Carroll SM, Overgoor ML, Tobin G, Barker JH. Acute ischemic preconditioning of skeletal muscle prior to flap elevation augments muscle-flap survival. Plast Reconstr Surg 1997; 100(1): 58-65.
30. Gürke L, Marx A, Sutter PM, Frentzel A, Salm T, Harder F, et al. Ischemic preconditioning improves post-ischemic skeletal muscle function. Am Surg 1996; 62(5): 391-394.
31. Pang CY, Yang RZ, Zhong A, Xu N, Boyd B, Forrest CR. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovac Res 1995; 29(6): 782-788.
32. Papanastasiou S, Estdale SE, Homer-Vanniasinkam S, Mathie RT. Protective effect of preconditioning and adenosine pretreatment in experimental skeletal muscle reperfusion injury. Br J Surg 1999; 86(7): 916-922.
33. Elliott GT. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J Mol Cell Cardiol 1998; 30(1): 3-17.
34. Klein M, Geoghegan J, Wangemann R, Bockler D, Schmidt K, Scheele J. Preconditioning of donor livers with prostaglanifin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury. Transplantation 1999; 67(8): 1128-1132.
35. Maulik N, Engelman RM, Wei Z, Liu X, Rousou JA, Flack JE, et al. Drug-induced heat-shock preconditioning improves postischemic ventricular recovery after cardiopulmonary bypass. Circulation 1995; 92(9 Suppl): II381-II388.
36. Meldrum DR, Cleveland JCJ, Sheridan BC, Rowland RT, Banerjee A, Harken AH. Cardiac preconditioning with calcium: clinically accessible myocardial protection. J Thorac Cardiovasc Surg 1996, 112(3): 778-786.
37. McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci 1983; 19(3): 205-266.
38. Li Y, Bickel KD, Im MJ, Hu L, Dellon AL, Vander K, et al. Effects of deferoxamine on ischemia/reperfusion injury after peripheral nerve compression. Ann Plast Surg 1996; 36(4): 365-369.
39. Katoh S, Toyama J, Kodama I, Kamiya K, Akita T, Abe T. Protective action of iron-chelating agents (catechol, immosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts. Eur Surg Res 1992; 24(6): 349-355.
40. Zavitsanos G, Huang L, Panza W, Serafin D, Klitzman B. Limiting impairment of muscle function following ischemia and reperfusion in rabbits. J Reconstr Microsurg 1996; 12(3): 183-187.
41. Watanabe BI, Limm W, Suehiro A, Suehiro G, Premaratne S, McNamara JJ. Failure of deferoxamine to reduce myocardial infarct size in a primate model of ischemia-reperfusion injury. J Surg Res 1993; 55(5): 537-542.
42. Fisher PW, Huang YC, Kennedy TP, Piantadosi CA. PO2-dependent hydroxyl radical production during ischemia-reperfusion lung injury. Am J Physiol 1993; 265(3 Pt 1): L279-L285.
43. Rios L, Cluzel J, Vennat JC, Menerath JM, Doly M. Comparison of intraocular treatment of DMTU and SOD following retinal ischemia in rats. J Ocul Pharmacol Ther 1999; 15(6): 547-556.
44. Roda JM, Carceller F, Pajares R, Diez-Tejedor E. Prevention of cerebral ischaemic reperfusion injury by intra-arterial administration of superoxide dismutase in the rat. Neurol Res 1991; 13(3): 160-163.
45. Kimura T, Fujiyama Y, Sasaki M, Andoh A, Fukuda M, Nakajima S, et al. The role of mucosal mast cell degranulation and free-radical generation in intestinal ischaemia-reperfusion injury in rats. Eur J Gastroenterol Hepatol 1998; 10(8): 659-666.
46. Knight KR, Mellow CG, Abbey PA, Angel MF, Lepore DA, Arnold LI, et al. Interaction between thromboxane and free radical mechanisms in experimental ischaemic rabbit skin flaps. Res Exp Med (Berl) 1990; 190(6): 423-433.
47. Chavez-Cartaya R, Jamieson NV, Ramirez P, Marin J, Pino-Chavez G. Free radical scavengers to prevent reperfusion injury following experimental warm liver ischaemia. Is there a real physiological benefit? Transpl Int 1999; 12(3): 213-221.
48. Kondo T, Terajima H, Todoroki T, Hirano T, Ito Y, Usia T, et al. Prevention of hepatic ischemia-reperfusion injury by SOD-DIVEMA conjugate. J Surg Res 1999; 85(1): 26-36.
49. Menger MD, Pelikan S, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: significance of " reflow paradox". Am J Physiol 1992; 263(6 Pt 2): H1901-H1906.
50. Giardino R, Capelli S, Fini M, Giavaresi G, Orienti L, Veronese FM, et al. Biopolymeric modification of superoxide dismutase (mPEG-SOD) to prevent muscular ischemia-reperfusion damage. Int J Artif Organs 1995; 18(3): 167-172.
51. Aoki Y, Nata M, Odaira T, Sagisaka K. Suppression of ischemia-reperfusion injury by liposomal superoxide dismutase in rats subjected to tourniquet shock. Int J Legal Med 1992; 105(1): 5-9.
52. Hardy SC, Homer-Vanniasinkam S, Gough MJ. Effect of free radical scavenging on skeletal muscle blood flow during postischaemic reperfusion. Br J Surg 1992; 79(12): 1289-1292.
53. Reikeras O, Ytrehus K. Oxygen radicals and scavenger enzymes in ischaemia-reperfusion injury of skeletal muscle. Scand J Clin Lab Invest 1992; 52(2): 113-118.
54. Kawasaki S, Sugiyama S, Ishiguro N, Ozawa T, Miura T. Implication of superoxide radicals on ischemia-reperfusion-induced skeletal muscle injury in rats. Eur Surg Res 1993; 25(3): 129-136.
55. Cronenwett JL, Lee KR, Shlafer M, Zelenock GB. The effect of ischemia-reperfusion derived oxygen free radicals on skeletal muscle calcium metabolism. Microcirc Endothelium Lymphatics 1989; 5(3-5): 171-187.
56. 2+ transport in ischemic and reperfused skeletal muscle. J Surg Res 1987; 42(1): 24-32.
57. Bowler DJ, McLaughlin R, Kelly CJ, O'Farrell DA, Moran, Bouchier-Hayes D. Recombinant human manganese superoxide dismutase attenuates early but not delayed skeletal muscle dysfunction following reperfusion injury. Eur J Vasc Endovasc Surg 1999; 18(3): 216-221.
58. Mao GD, Thomas PD, Lopaschuk GD, Poznansky MJ. Superoxide dismutase (SOD)-catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. J Biol Chem 1993; 268(1): 416-420.
59. Nagel E, Meyer ZV, Bartels M, Pichimayr R. Antioxidative vitamins in prevention of ischemia/reperfusion injury. Int J Vitam Nutr Res 1997; 67(5): 298-306.
60. Sinatra ST, DeMarco J. Free radicals, oxidative stress, oxidized low density lipoprotein (LDL), and the heart: antioxidants and other strategies to limit cardiovascular damage. Conn Med 1995; 59(10): 579-588.
61. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000; 47(3): 446-456.
62. Bulger EM, Helton WS. Nutrient antioxidants in gastrointestinal diseases. Gastroenterol Clin North Am 1998; 27(2): 403-419.
63. Westhuyzen J, Cochrane AD, Tesar PJ, Mau T, Cross DB, Frenneaux MP, et al. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations [see comments]. J Thorac Cardiovasc Surg 1997; 113(5): 942-948.
64. Spark JI, Chetter IC, Gallavin L, Kester RC, Guillou PJ, Scott DJ. Reduced total antioxidant capacity predicts ischaemia-reperfusion injury after femorodistal bypass. Br J Surg 1998; 85(2): 221-225.
65. Nakamura M, Ozaki M, Fuchinoue S, Teraoka S, Ota K. Ascorbic acid prevents ischemia-reperfusion injury in the rat small intestine. Transpl Int 1997; 10(2): 89-95.
66. Zaccaria A, Weinzweig N, Yoshitake M, Matsuda T, Cohen M. Vitamin C reduces ischemia-reperfusion injury in a rat epigastric island skin flap model. Ann Plast Surg 1994; 33(6): 620-623.
67. Kearns SR, Kelly CJ, Barry M, Abdih H, Condron C, Leahy A, et al. Vitamin C reduces ischaemia-reperfusion-induced acute lung injury. Eur J Vasc Endovasc Surg 1999; 17(6): 533-536.
68. Kearns SR, Moneley D, Murray P, Kelly C, Daly AF. Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle. J Bone Joint Surg Br 2001; 83(8): 1202-1206.
69. Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg 1994; 42(5): 276-278.
70. Westhuyzen J, Cochrane AD, Tesar PJ, Mau T, Cross DB, Frenneaux MP, et al. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations [see comments]. J Thorac Cardiovasc Surg 1997; 113(5): 942-948.
71. Nugent D, Newton H, Gallivan L, Gosden RG. Protective effect of vitamin E on ischaemia-reperfusion injury in ovarian grafts. J Reprod Fertil 1998; 114(2): 341-346.
72. Punz A, Nanobashvili J, Neumayer C, Blumer R, Gassner R, Fuegl A, et al. Multivitamin administration before ischemia reduces ischemia-reperfusion injury in rabbit skeletal muscle. Clin Nutr 1999; 18(4): 219-226.
73. Cerwenka H, Bacher H, Werkgartner G, El-Shabrawi A, Quehenberger F, Hauser H, et al. Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injury. Hepatogastroenterology 1998; 45(21): 777-782.
74. Tanaka H, Zhu Y, Zhang S, Ishizaki N, Jin MB, Azuma T, et al. Lazaroid U-74500A for warm ischemia and reperfusion injury of the canine small intestine. J Am Coll Surg 1997; 184(4): 389-396.
75. Tanoue Y, Morita S, Ochiai Y, Zhang QW, Hisahara M, Miyamoto K, et al. Successful twenty-four-hour canine lung preservation with lazaroid U74500A. J Heart Lung Transplant 1996; 15(1 Pt 1): 43-50.
76. Kuwaki K, Komatsu K, Sohma H, Abe T. Lazaroid U74389G ameliorates ischemia-reperfusion injury in the rat lung transplant model. Ann Thorac Cardiovasc Surg 1999; 5(1): 11-17.
77. Nediani C, Perna AM, Liguori P, Formigli L, Ibba-Manneschi L, Zecchi-Orlandini S, et al. Beneficial eftects of the 21-aminosteroid U 74389G on the ischemia-reperfusion damage in pig hearts. J Mol Cell Cardiol 1997; 29(10): 2825-2835.
78. Perna AM, Liguori P, Bonacchi M, Laino GM, Nediani C, Fiorillo C, et al. Protection of rat heart from ischaemia-reperfusion injury by the 21-aminosteroid U-74389G. Pharmacol Res 1996; 34(1-2): 25-31.
79. Takahashi T, Takeyoshi I, Hasegawa Y, Koyano T, Yamagishi T, Oshima K, et al. Cardioprotective effects of Lazaroid U-74389G on ischemia-reperfusion injury in canine hearts. J Heart Lung Transplant 1999; 18(4): 285-291.
80. Potter RF, Ellis CG, Tyml K, Groom AC. Effect of superoxide dismutase and 21-aminosteroids (lazaroids) on microvascular perfusion following ischemia-reperfusion in skeletal muscle. Int J Microcirc Clin Exp 1994; 14(6): 313-318.
81. Hirose J, Yamaga M, Ide J, Tanoue M, Takagi K. Reduced ischemia-reperfusion injury in muscle. Experiments in rats with EPC-K1, a new radical scavenger. Acta Orthop Scand 1997; 68(4): 369-373.
82. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 1999; 27(1-2): 160-169.
83. Finnegan NM, Redmond HP, Bouchier-Hayes DJ. Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury. Cancer 1998; 82(1): 186-199.
84. Redmond HP, Wang JH, Bouchier-Hayes D. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 1996; 131(12): 1280-1288.
85. Matsuda T, Takuma K, Kishida Y, Azuma J, Baba A. Protective effect of taurine against reperfusion injury in cultured rat astrocytes. Adv Exp Med Biol 1996; 403: 491-497.
86. Chahine R, Feng J. Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. Arzneimittelforschung 1998; 48(4): 360-364.
87. Oz E, Erbas D, Gelir E, Aricioqlu A. Taurine and calcium interaction in protection of myocardium exposed to ischemic reperfusion injury. Gen Pharmacol 1999; 33(2): 137-141.
88. Raschke P, Massoudy P, Becker BF. Taurine protects the heart from neutrophil-induced reperfusion injury. Free Radic Biol Med 1995; 19(4): 461-471.
89. Li P, Kang Y, Wang GX. Prophylactic effects of taurine and diltiazem, alone or combined, on reperfusion arrhythmias in rats. Zhongguo Yao Li Xue Bao 1996; 17(2): 122-124.
90. Allo SN, Bagby L, Schaffer SW. Taurine depiction, a novel mechanism for cardioprotection from regional ischemia. Am J Physiol 1997; 273(4 Pt 2): H1956-H1961.
91. Wettstein M, Haussinger D. Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver. Hepatology 1997; 26(6): 1560-1566.
92. Wettstein M, Haussinger D. Taurine attenuates cold ischemia-reoxygenation injury in rat liver. Transplantation 2000; 69(11): 2290-2296.
93. Kerai MD, Waterfield CJ, Kenyon SH, Asker DS, Timbrell JA. Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats. Amino Acids 1998; 15(1-2): 53-76.
94. Schneeberger H, Schleibner S, Illner WD, Messmer K, Land W. The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation. Clin Transpl 1993;219-232.
95. Wingenfeld P, Gehrmann U, Strubind S, Minor T, Isselhard W, Michalk DV. Long-lasting hypoxic preservation of porcine kidney cells. Beneficial effect of taurine on viability and metabolism in a simplified transplantation model. Adv Exp Med Biol 1996; 403: 203-212.
96. Wingenfeld P, Minor T, Gehrmann U, Strubind S, Isselhard W, Michalk D. Hypoxic cellular deterioration and its prevention by the amino acid taurine in a transplantation model with renal tubular cells (LLC-PK1). In vitro Cell Dev Biol Anim 1995; 31(7): 483-486.
97. Wingenfeld P, Strubind S, Gehrmann U, Minor T, Isselhard W, Michalk D. Protecting effect of taurine against hypoxic cell damage in renal tubular cells cultured in different transplant preservation solutions. Adv Exp Med Biol 1994; 359: 159-169.
98. Licht C, Kriegesmann E, Minor T, Wingenfeld P, Isselhard W, Michalk DV. Influence of taurine supplementation on ischemic preservation of the isolated rat kidney. Adv Exp Med Biol 1998; 442: 201-206.
99. Michalk DV, Hoffmann B, Minor T. Taurine reduces renal ischemia/reperfusion injury in the rat. Adv Exp Med Biol 2003; 526: 49-56.
100. Zhou M, Ma T, Tseng MT. Effects of taurine and ketamine on bovine retinal membrane lipid peroxidation. Neuroscience 1991; 45(2): 461-465.
101. Delbarre B, Delbarre G, Calinon F. Taurine in gerbil retina: changes during ischemia reperfusion/insult (I.R.I.) and aging. J Ocul Pharmacol Ther 1996; 12(1): 65-73.
102. Zhang J, Niu X. Changes of monoamines, purines and amino acids in rat striatum as measured by intercerebral microdialysis during ischemia/reperfusion. Chin Med Sci J 1994; 9(4): 225-229.
103. Son M, Ko JI, Kim WB, Kang HK, Kim BK. Taurine can ameliorate inflammatory bowel disease in rats. Adv Exp Med Biol 1998; 442: 291-298.
104. Son MW, Ko JI, Doh HM, Kim WB, Park TS, Shim MJ, et al. Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. Arch Pharm Res 1998; 21(5): 531-536.
105. Yoshida WB, Alasio T, Mazziotta R, Qin F, Kashani M, Lee S, et al. Effect of alpha-tocopherol, taurine and selenium on the attenuation of ischemia/reperfusion injury of splanchnic organs. Cardiovasc Surg 1998; 6(2): 178-187.
106. Barry MC, Kelly CJ, Abdih H, Watson RW, Stapleton P, Sheehan SJ, et al. Differential effects of lower limb revascularisation on organ injury and the role of the amino acid taurine. Eur J Vasc Endovasc Surg 1997; 13(2): 193-201.
107. McLaughlin R, Bowler D, Kelly CJ, Kay E, Bouchier-Hayes D. Taurine protects against early and late skeletal muscle dysfunction secondary to ischaemia reperfusion injury. Eur J Surg 2000; 166(5): 375-379.
108. Westhuyzen J, Cochrane AD, Tesar PJ, Mau T, Cross DB, Frenneaux MP, et al. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1997; 113(5): 942-948.
109. Suleiman MS, Moffatt AC, Dihmis WC, Caputo M, Huffer JA, Angelini GD, et al. Effect of ischaemia and reperfusion on the intracellular concentration of taurine and glutamine in the hearts of patients undergoing coronary artery surgery. Biochim Biophys Acta 1997; 1324(2): 223-231.
110. Ascione R, Gomes WJ, Angelini GD, Bryan AJ, Suleiman MS. Warm blood cardioplegia reduces the fall in the intracellular concentration of taurine in the ischaemic/reperfused heart of patients undergoing aortic valve surgery. Amino Acids 1998; 15(4): 339-350.
111. Milei J, Ferreira R, Llesuy S, Forcada P, Covarrubias J, Boveris A. Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am Heart J 1992; 123(2): 339-345.
112. Gennaro R, Zanetti M, Benincasa M, Podda E, Miam M. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr Pharm Design 2002; 8(9): 763-78.
113. Kurowska EM. Nitric oxide therapies in vascular diseases. Curr Pharm Design 2002; 8(3): 155-66.
114. Takano H, Ohtsuka M, Akazawa H, Toko H, Harada M, Hasegawa H, et al. Pleiotropic effects of cytokines on acute myocardial infarction. C-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Design 2003; 9(14): 1121-7.